A novel c-Met targeting antibody drug conjugate for NSCLC

被引：1
|
作者：
Li, Lingna
Fells, Cathrine
Guo, Julia
Muyot, Pia
Gros, Edwige
Zhang, Yanliang
Sun, Yingqing
Zhang, Hong
Fu, Yanwen
Zhu, Tong
Cao, Jian
Kaufmann, Gunnar
Chen, Gang
Miao, Zhenwei
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3897
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3897
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A novel c-Met/EGFR bispecific targeting antibody drug conjugate for NSCLC
    Chen, Gang
    Li, Lingna
    Muyot, Pia
    Gros, Edwige
    Zhang, Yanliang
    Sun, Yingqing
    Zhang, Hong
    Fu, Yanwen
    Lee, Alice
    Cao, Jian
    Kaufmann, Gunnar
    Miao, Zhenwei
    CANCER RESEARCH, 2015, 75
  • [2] BYON3521, a novel effective and safe c-Met targeting antibody-drug conjugate.
    Groothuis, Patrick
    Jacobs, Danielle
    Hermens, Inge
    Damming, Desiree
    Mattaar, Ellen
    Rouwette, Myrthe
    van der Vleuten, Monique
    Sesink, Aloys
    Dijcks, Fred
    Coumans, Ruud
    Blomenrohr, Marion
    Ubink, Ruud
    van der Lee, Miranda
    Dokter, Wim H. A.
    CANCER RESEARCH, 2021, 81 (13)
  • [3] A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
    Jin, Yangbing
    Zhang, Zehui
    Zou, Siyi
    Li, Fanlu
    Chen, Hao
    Peng, Chenghong
    Deng, Xiaxing
    Wen, Chenlei
    Shen, Baiyong
    Zhan, Qian
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancers
    Fujita, Ryo
    Blot, Vincent
    Wong, Eley
    Stewart, Christine
    Lieuw, Vincent
    Richardson, Robyn
    Banah, Ammar
    Villicana, Jose
    Timmer, Anjuli
    Coronella, Julia
    Newman, Roland
    Gymnopoulos, Marco
    CANCER BIOLOGY & THERAPY, 2020, 21 (06) : 549 - 559
  • [5] Antibody targeting of the HGF/c-Met pathway
    Bottaro, D. P.
    ANNALS OF ONCOLOGY, 2008, 19 : 22 - 22
  • [6] First in human dose-escalation trial with the c-MET targeting antibody-drug conjugate BYON3521
    Kotecki, N.
    van Herpen, C. M. L.
    Curigliano, C.
    Hendriks, M.
    Vermaas, T. C.
    Corrigan, L.
    Belli, C.
    Jungels, C.
    Desar, I. M. E.
    Koper, N. P.
    Schellens, J. H. M.
    Banerji, U.
    CANCER RESEARCH, 2023, 83 (08)
  • [7] Engineering hydrophobicity and manufacturability for optimized biparatopic antibody-drug conjugates targeting c-MET
    Evers, Andreas
    Krah, Simon
    Demir, Deniz
    Gaa, Ramona
    Elter, Desislava
    Schroeter, Christian
    Zielonka, Stefan
    Rasche, Nicolas
    Dotterweich, Julia
    Knuehl, Christine
    Doerner, Achim
    MABS, 2024, 16 (01)
  • [8] SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
    Yang, Chang-yong
    Wang, Lei
    Sun, Xing
    Tang, Mi
    Quan, Hai-tian
    Zhang, Lian-shan
    Lou, Li-guang
    Gou, Shao-hua
    ACTA PHARMACOLOGICA SINICA, 2019, 40 (07) : 971 - 979
  • [9] SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
    Chang-yong Yang
    Lei Wang
    Xing Sun
    Mi Tang
    Hai-tian Quan
    Lian-shan Zhang
    Li-guang Lou
    Shao-hua Gou
    Acta Pharmacologica Sinica, 2019, 40 : 971 - 979
  • [10] cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody-Drug Conjugate Targeting c-Met Overexpression Tumors
    Min, Byeongkwi
    Jin, Jonghwa
    Kim, Hyeree
    Her, Nam-Gu
    Park, Changsik
    Kim, Donggeon
    Yang, Jehoon
    Hwang, Juhyeon
    Kim, Eunmi
    Choi, Minji
    Song, Ho Young
    Nam, Do-Hyun
    Yoon, Yeup
    ACS OMEGA, 2020, 5 (40): : 25798 - 25809
12345